PE97199A1 - Composiciones solubilizadas de sertralina - Google Patents

Composiciones solubilizadas de sertralina

Info

Publication number: PE97199A1
Authority: PE; Peru
Prior art keywords: esters; sterby; soltrilized; sertralina; compositions
Prior art date: 1997-07-01

Application number

PE1998000573A

Other languages

English (en)

Spanish (es)

Inventor

Ravi Mysore Shanker

Scott Max Herbig

Dwayne Thomas Friesen

James Blair West

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1998-06-26

Publication date

1999-10-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE97199(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-26 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

1999-10-05 Publication of PE97199A1 publication Critical patent/PE97199A1/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PE1998000573A 1997-07-01 1998-06-26 Composiciones solubilizadas de sertralina PE97199A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5141397P	1997-07-01	1997-07-01

Publications (1)

Publication Number	Publication Date
PE97199A1 true PE97199A1 (es)	1999-10-05

Family

ID=21971159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PE1998000573A PE97199A1 (es)	1997-07-01	1998-06-26	Composiciones solubilizadas de sertralina

Country Status (34)

Country	Link
EP (1)	EP0999829A1 (no)
JP (1)	JP2000514100A (no)
KR (1)	KR100366373B1 (no)
CN (1)	CN1261794A (no)
AP (1)	AP1192A (no)
AR (3)	AR015917A1 (no)
AU (1)	AU742535B2 (no)
BG (1)	BG103918A (no)
BR (1)	BR9810739A (no)
CA (1)	CA2290974C (no)
CO (1)	CO4940495A1 (no)
DZ (1)	DZ2548A1 (no)
EA (1)	EA002481B1 (no)
HN (1)	HN1998000102A (no)
HR (1)	HRP980377A2 (no)
HU (1)	HUP0002236A3 (no)
ID (1)	ID23429A (no)
IL (1)	IL133076A (no)
IS (1)	IS5260A (no)
MA (1)	MA24587A1 (no)
NO (1)	NO996520L (no)
OA (1)	OA11243A (no)
PA (1)	PA8454301A1 (no)
PE (1)	PE97199A1 (no)
PL (1)	PL337804A1 (no)
SK (1)	SK181099A3 (no)
TN (1)	TNSN98124A1 (no)
TR (1)	TR199903297T2 (no)
TW (1)	TW550087B (no)
UA (1)	UA67741C2 (no)
UY (1)	UY25071A1 (no)
WO (1)	WO1999001120A1 (no)
YU (1)	YU68299A (no)
ZA (1)	ZA985708B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003518485A (ja)	1999-12-23	2003-06-10	ファイザー・プロダクツ・インク	向上された薬物濃度を与える医薬組成物
US20030086972A1 (en) *	2000-08-09	2003-05-08	Appel Leah E.	Hydrogel-driven drug dosage form
WO2002017918A2 (en)	2000-08-30	2002-03-07	Pfizer Products Inc.	Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) *	2003-03-31	2004-09-30	Lipari John M.	Alpha-hydroxy acid ester drug delivery compositions and methods of use
KR101500020B1 (ko) *	2007-03-12	2015-03-06	디에스엠 아이피 어셋츠 비.브이.	미용 조성물
EP2520299A1 (en) *	2009-12-29	2012-11-07	Kowa Co., Ltd.	Solid pharmaceutical composition for oral administration
EP2520300A4 (en) *	2009-12-29	2013-05-08	Kowa Co	PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
CN109908354A (zh) *	2017-12-12	2019-06-21	万特制药(海南)有限公司	盐酸舍曲林口服浓缩液及其制备工艺
CN114894736A (zh) *	2022-05-20	2022-08-12	中化地质矿山总局地质研究院	一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
EP0415612B1 (en) *	1989-08-30	1993-11-10	Pfizer Inc.	Use of sertraline for the treatment of chemical dependencies
ZA97976B (en) *	1996-04-05	1997-08-18	Alza Corp	Uniform drug delivery theraphy.

1998
- 1998-06-15 UA UA99116391A patent/UA67741C2/uk unknown
- 1998-06-15 CN CN98806763A patent/CN1261794A/zh active Pending
- 1998-06-15 PL PL98337804A patent/PL337804A1/xx unknown
- 1998-06-15 CA CA002290974A patent/CA2290974C/en not_active Expired - Fee Related
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/ko not_active IP Right Cessation
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/xx unknown
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/pt not_active Application Discontinuation
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/en not_active Application Discontinuation
- 1998-06-15 EA EA199900962A patent/EA002481B1/ru unknown
- 1998-06-15 EP EP98923019A patent/EP0999829A1/en not_active Withdrawn
- 1998-06-15 YU YU68299A patent/YU68299A/sh unknown
- 1998-06-15 ID IDW991701A patent/ID23429A/id unknown
- 1998-06-15 SK SK1810-99A patent/SK181099A3/sk unknown
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/hu unknown
- 1998-06-15 IL IL13307698A patent/IL133076A/xx not_active IP Right Cessation
- 1998-06-15 JP JP11506774A patent/JP2000514100A/ja active Pending
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-25 TW TW087110267A patent/TW550087B/zh active
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/es not_active Application Discontinuation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/es unknown
- 1998-06-29 UY UY25071A patent/UY25071A1/es not_active IP Right Cessation
- 1998-06-29 AR ARP980103146A patent/AR015917A1/es not_active Application Discontinuation
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/xx unknown
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/fr unknown
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/xx active
- 1998-06-30 MA MA25146A patent/MA24587A1/fr unknown
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/es unknown
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/hr not_active Application Discontinuation
- 1998-07-01 CO CO98037137A patent/CO4940495A1/es unknown
1999
- 1999-11-19 IS IS5260A patent/IS5260A/is unknown
- 1999-11-23 BG BG103918A patent/BG103918A/xx unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/no not_active Application Discontinuation
2003
- 2003-06-19 AR ARP030102179A patent/AR040279A2/es unknown
- 2003-06-19 AR ARP030102180A patent/AR040280A2/es unknown

Also Published As

Publication number	Publication date
MA24587A1 (fr)	1998-12-31
UY25071A1 (es)	2000-12-29
OA11243A (en)	2003-07-24
UA67741C2 (uk)	2004-07-15
AR015917A1 (es)	2001-05-30
EP0999829A1 (en)	2000-05-17
WO1999001120A1 (en)	1999-01-14
IL133076A (en)	2003-12-10
HUP0002236A3 (en)	2003-12-29
EA199900962A1 (ru)	2000-08-28
CA2290974A1 (en)	1999-01-14
AU742535B2 (en)	2002-01-03
PA8454301A1 (es)	2000-09-29
BG103918A (en)	2000-07-31
TR199903297T2 (xx)	2000-07-21
PL337804A1 (en)	2000-09-11
DZ2548A1 (fr)	2003-02-08
AR040280A2 (es)	2005-03-23
JP2000514100A (ja)	2000-10-24
YU68299A (sh)	2002-06-19
ZA985708B (en)	2000-01-10
IS5260A (is)	1999-11-19
CO4940495A1 (es)	2000-07-24
BR9810739A (pt)	2000-09-12
KR20010013365A (ko)	2001-02-26
HUP0002236A2 (hu)	2003-08-28
AR040279A2 (es)	2005-03-23
CA2290974C (en)	2004-04-27
AP9801280A0 (en)	1998-06-30
TW550087B (en)	2003-09-01
SK181099A3 (en)	2000-07-11
NO996520L (no)	2000-02-29
HN1998000102A (es)	1999-01-08
IL133076A0 (en)	2001-03-19
TNSN98124A1 (fr)	2005-03-15
NO996520D0 (no)	1999-12-28
EA002481B1 (ru)	2002-06-27
AP1192A (en)	2003-07-23
KR100366373B1 (ko)	2003-01-14
ID23429A (id)	2000-04-20
HRP980377A2 (en)	1999-04-30
AU7544898A (en)	1999-01-25
CN1261794A (zh)	2000-08-02

Similar Documents

Publication	Publication Date	Title
ES2529167T3 (es)	2015-02-17	Método para utilizar lípidos neutros para modificar la liberación in vivo desde liposomas multivesiculares
CR6656A (es)	2004-04-29	Forma de dosificacion de farmacos accionada por un hidrogel
ES2151464T3 (es)	2002-12-16	Preparacion para aplicacion externa que comprende tranilast y procedimiento para producirla.
ES2145557T3 (es)	2000-07-01	Composiciones de ablandamiento del agua y composiciones detergentes.
AR012531A1 (es)	2000-10-18	Composicion para cuidado personal, composicion para repasador y metodo para minimizar o reducir la comezon o quemado de la piel a causa de composicionespara cuidado personal que contienen acido.
MX9202407A (es)	1992-11-01	Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
CO5640073A2 (es)	2006-05-31	Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
ATE438304T1 (de)	2009-08-15	Eine säure und/oder alkohol enthaltendes wasserstoffperoxid-desinfektionsmittel
ES2195798T1 (es)	2003-12-16	Formulacion para mujeres menopausicas.
PE20000522A1 (es)	2000-07-23	Activos donantes protonicos en articulos absorbentes
ATE370730T1 (de)	2007-09-15	Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
AR015884A1 (es)	2001-05-30	Una composicion cosmetica para su uso en aplicaciones para el cuidado personal, que comprende un portador y una biguanida polimerica, uso de la misma y uso de una biguanida polimerica.
BR9914799A (pt)	2001-07-10	Sistema conservante para composições farmacêuticas administráveis topicamente contendo um sabão de ácido graxo/aminoácido
PE97199A1 (es)	1999-10-05	Composiciones solubilizadas de sertralina
AR018357A1 (es)	2001-11-14	Acido petroselinico en una composicion y en un metodo para reducir o eliminar la irritacion o la picazon de la piel inducida por los alfa-hidroxiacidos
AR056268A1 (es)	2007-10-03	Tabletas que comprenden una sustancia biologicamente activa y un excipiente
PT697814E (pt)	2003-11-28	Formulacoes para verter que contem material polimerico glicois e gliceridos
AR003893A1 (es)	1998-09-09	Composicion cosmetica transparente en barra con 2-metil-1,3-propanodiol.
BRPI0407652A (pt)	2006-02-21	método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição
ES2177677T3 (es)	2002-12-16	Soluciones estables de 2-cloro-2`desoxiadenosina.
BR9814756A (pt)	2000-10-03	Composição sólida seca para liberação de droga, processo para a preparação da mesma, uso de um grande número de pequenas esferas que contêm uma matriz polimérica composta de um polietileno glicol ou de uma mistura de polietileno glicóis
MY143793A (en)	2011-07-15	Non-tabletted, chewable, individually dosed administration forms
ES2190819T3 (es)	2003-08-16	Procedimiento de preparacion de formulaciones galenicas noveles que contienen fenobrinato, formulaciones galenicas asi obtenidas y sus aplicaciones.
ES2143481T3 (es)	2000-05-16	Comprimido de valproato de sodio de liberacion lenta.
AR024313A1 (es)	2002-09-25	Microgranulos de sulfato de morfina, procedimiento para su preparacion y composicion que los contiene

Legal Events

Date	Code	Title	Description
2002-09-30	FG	Grant, registration
2008-01-31	FD	Application declared void or lapsed